The ABC Bleeding risk score
The ABC (Age, Biomarkers, Clinical history) bleeding risk score has been developed to predict the risk of bleeding in patients with atrial fibrillation. The ABC bleeding risk score is internally and externally validated using two clinical trial databases.

This model is intended to be used for patients who have been diagnosed with either paroxysmal, persistent or permanent atrial fibrillation or atrial flutter and with at least one or more of the risk factors. The full inclusion and exclusion criteria are stated in the intended use.
Research authors: Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, John H Alexander, Stuart J Connolly, John W Eikelboom, Michael D Ezekowitz, Claes Held, Elaine M Hylek, Renato D Lopes, Agneta Siegbahn, Salim Yusuf, Christopher B Granger, Lars Wallentin, ARISTOTLE and RE-LY Investigators
Version: 2.5
  • Public
  • Cardiology
  • {{ modelType }}
V-2.5-2326.23.10.10
(01)08720299526433(8012)v2.5(4326)231010(240)2326
Download the User manual and consult the Intended purpose.
  • Details
  • Intended purpose
  • Electronic label
  • Release Notes
  • User manual
Units

{{section.title}}

Calculate the result

Set more parameters to perform the calculation

The calculated bleeding risk is: %

{{ resultSubheader }}
{{ chart.title }}
Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

Conditional information

The current model calculates the risk of bleeding occurring within the next one, two, or three years. Even though the tool may support decision involving the initiation of anticoagulant treatment, a high bleeding risk alone should not immediately lead to withholding anticoagulation. 

The ABC bleeding risk score was externally validated and compared head-to-head with similar prediction models such as the HAS-BLED score. The external validation of the ABC score resulted in a c-index of 0.69 (95% CI: 0.66 - 0.71) versus 0.62 (95% CI: 0.60 - 0.64) for the HAS-BLED score. 

Depending on the selected biomarker, the model may perform slightly different. Still, all possible combinations of biomarkers resulted in similar model performance in terms of discrimination with C-indexes ranging between 0.68 and 0.71 on internal validation. Each of the six ABC bleeding risk score models performed better than the HAS-BLED score. 
 

{{ file.classification }}
PRO
Note
Notes are only visible in the result download and will not be saved by Evidencio

Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.

Underlying models Part of
logo

Please sign in to enable Evidencio print features

In order to use the Evidencio print features, you need to be logged in.
If you don't have an Evidencio Community Account you can create your free personal account at:

https://www.evidencio.com/registration

Printed results - Examples {{ new Date().toLocaleString() }}


Evidencio Community Account Benefits


With an Evidencio Community account you can:

  • Create and publish your own prediction models.
  • Share your prediction models with your colleagues, research group, organization or the world.
  • Review and provide feedback on models that have been shared with you.
  • Validate your models and validate models from other users.
  • Find models based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction models and their data.
  • Use patient specific protocols and guidelines based on sequential models and decision trees.
  • Stay up-to-date with new models in your field as they are published.
  • Create your own lists of favorite models and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.


Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.
Evidencio v3.31 © 2015 - 2024 Evidencio. All Rights Reserved